How enhancers regulate wavelike gene expression patterns

  1. Christine Mau
  2. Heike Rudolf
  3. Frederic Strobl
  4. Benjamin Schmid
  5. Timo Regensburger
  6. Ralf Palmisano
  7. Ernst HK Stelzer
  8. Leila Taher  Is a corresponding author
  9. Ezzat El-Sherif  Is a corresponding author
  1. Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
  2. Goethe Universität Frankfurt am Main, Germany
  3. Graz University of Technology, Austria
  4. The University of Texas Rio Grande Valley, United States

Abstract

A key problem in development is to understand how genes turn on or off at the right place and right time during embryogenesis. Such decisions are made by non-coding sequences called 'enhancers'. Much of our models of how enhancers work rely on the assumption that genes are activated de novo as stable domains across embryonic tissues. Such view has been strengthened by the intensive landmark studies of the early patterning of the anterior-posterior (AP) axis of the Drosophila embryo, where indeed gene expression domains seem to arise more or less stably. However, careful analysis of gene expression patterns in other model systems (including the AP patterning in vertebrates and short-germ insects like the beetle Tribolium castaneum) painted a different, very dynamic view of gene regulation, where genes are oftentimes expressed in a wavelike fashion. How such gene expression waves are mediated at the enhancer level is so far unclear. Here we establish the AP patterning of the short-germ beetle Tribolium as a model system to study dynamic and temporal pattern formation at the enhancer level. To that end, we established an enhancer prediction system in Tribolium based on time- and tissue-specific ATAC-seq and an enhancer live reporter system based on MS2 tagging. Using this experimental framework, we discovered several Tribolium enhancers, and assessed the spatiotemporal activities of some of them in live embryos. We found our data consistent with a model in which the timing of gene expression during embryonic pattern formation is mediated by a balancing act between enhancers that induce rapid changes in gene expression patterns (that we call 'dynamic enhancers') and enhancers that stabilizes gene expression patterns (that we call 'static enhancers'). However, more data is needed for a strong support for this or any other alternative models.

Data availability

Raw sequence files and scaled coverage tracks (in bigWig format) have been deposited in the Gene Expression Omnibus database under accession number GSE235410. Scaled coverage tracks were also uploaded to the iBeetleBase Genome Browser (https://ibeetle-base.uni-goettingen.de/genomebrowser/) (107). Matlab codes for the Speed Regulation and Enhancer Switching models can be found in (Kuhlmann L, El-Sherif E. Speed regulation and gradual enhancer switching models as flexible and evolvable patterning mechanisms. BioRxiv. 2018 Feb 7), and can be modified based on information and parameter values indicated in Materials and Methods (Computational Modeling) to generate the simulations presented in this study. Generated transgenic Tribolium lines are available upon request.

The following data sets were generated

Article and author information

Author details

  1. Christine Mau

    Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Heike Rudolf

    Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Frederic Strobl

    Buchmann Institute for Molecular Life Sciences, Goethe Universität Frankfurt am Main, Frankfurt am Main, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Benjamin Schmid

    Optical Imaging Centre Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9327-2296
  5. Timo Regensburger

    Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Ralf Palmisano

    Optical Imaging Centre Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4283-2115
  7. Ernst HK Stelzer

    Buchmann Institute for Molecular Life Sciences, Goethe Universität Frankfurt am Main, Frankfurt am Main, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1545-0736
  8. Leila Taher

    Institute of Biomedical Informatics, Graz University of Technology, Graz, Austria
    For correspondence
    leila.taher@tugraz.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2013-5426
  9. Ezzat El-Sherif

    Department of Biology, The University of Texas Rio Grande Valley, Edinburg, United States
    For correspondence
    ezzat.elsherif@utrgv.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1738-8139

Funding

Deutsche Forschungsgemeinschaft (EL 870/2-1)

  • Ezzat El-Sherif

Studienstiftung des Deutschen Volkes

  • Christine Mau

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Ariel D. Chipman, The Hebrew University of Jerusalem, Israel

Version history

  1. Preprint posted: September 10, 2022 (view preprint)
  2. Received: November 16, 2022
  3. Accepted: July 10, 2023
  4. Accepted Manuscript published: July 11, 2023 (version 1)
  5. Version of Record published: July 25, 2023 (version 2)

Copyright

© 2023, Mau et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,270
    views
  • 267
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Christine Mau
  2. Heike Rudolf
  3. Frederic Strobl
  4. Benjamin Schmid
  5. Timo Regensburger
  6. Ralf Palmisano
  7. Ernst HK Stelzer
  8. Leila Taher
  9. Ezzat El-Sherif
(2023)
How enhancers regulate wavelike gene expression patterns
eLife 12:e84969.
https://doi.org/10.7554/eLife.84969

Share this article

https://doi.org/10.7554/eLife.84969

Further reading

    1. Computational and Systems Biology
    2. Evolutionary Biology
    Ryan T Bell, Harutyun Sahakyan ... Eugene V Koonin
    Research Article

    A comprehensive census of McrBC systems, among the most common forms of prokaryotic Type IV restriction systems, followed by phylogenetic analysis, reveals their enormous abundance in diverse prokaryotes and a plethora of genomic associations. We focus on a previously uncharacterized branch, which we denote coiled-coil nuclease tandems (CoCoNuTs) for their salient features: the presence of extensive coiled-coil structures and tandem nucleases. The CoCoNuTs alone show extraordinary variety, with three distinct types and multiple subtypes. All CoCoNuTs contain domains predicted to interact with translation system components, such as OB-folds resembling the SmpB protein that binds bacterial transfer-messenger RNA (tmRNA), YTH-like domains that might recognize methylated tmRNA, tRNA, or rRNA, and RNA-binding Hsp70 chaperone homologs, along with RNases, such as HEPN domains, all suggesting that the CoCoNuTs target RNA. Many CoCoNuTs might additionally target DNA, via McrC nuclease homologs. Additional restriction systems, such as Type I RM, BREX, and Druantia Type III, are frequently encoded in the same predicted superoperons. In many of these superoperons, CoCoNuTs are likely regulated by cyclic nucleotides, possibly, RNA fragments with cyclic termini, that bind associated CARF (CRISPR-Associated Rossmann Fold) domains. We hypothesize that the CoCoNuTs, together with the ancillary restriction factors, employ an echeloned defense strategy analogous to that of Type III CRISPR-Cas systems, in which an immune response eliminating virus DNA and/or RNA is launched first, but then, if it fails, an abortive infection response leading to PCD/dormancy via host RNA cleavage takes over.

    1. Computational and Systems Biology
    Skander Kazdaghli, Iordanis Kerenidis ... Philip Teare
    Research Article

    Imputing data is a critical issue for machine learning practitioners, including in the life sciences domain, where missing clinical data is a typical situation and the reliability of the imputation is of great importance. Currently, there is no canonical approach for imputation of clinical data and widely used algorithms introduce variance in the downstream classification. Here we propose novel imputation methods based on determinantal point processes (DPP) that enhance popular techniques such as the multivariate imputation by chained equations and MissForest. Their advantages are twofold: improving the quality of the imputed data demonstrated by increased accuracy of the downstream classification and providing deterministic and reliable imputations that remove the variance from the classification results. We experimentally demonstrate the advantages of our methods by performing extensive imputations on synthetic and real clinical data. We also perform quantum hardware experiments by applying the quantum circuits for DPP sampling since such quantum algorithms provide a computational advantage with respect to classical ones. We demonstrate competitive results with up to 10 qubits for small-scale imputation tasks on a state-of-the-art IBM quantum processor. Our classical and quantum methods improve the effectiveness and robustness of clinical data prediction modeling by providing better and more reliable data imputations. These improvements can add significant value in settings demanding high precision, such as in pharmaceutical drug trials where our approach can provide higher confidence in the predictions made.